on September 13, 2007
Published online before print September 13, 2007, doi: 10.1161/ATVBAHA.107.150284
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 23, 2005
Accepted on August 31, 2007
Hypoxia-Induced Mediators of Stem/Progenitor Cell Trafficking Are Increased in Children With Hemangioma
Mark E. Kleinman ;
From the Stanford University School of Medicine (M.E.K., E.I.C., G.C.G.), Children’s Surgical Research Program, Stanford, Calif; and New York University School of Medicine (M.R.G., S.S.C., K.M.B., D.J.C., O.M.T.), Institute of Reconstructive Plastic Surgery, New York.
* To whom correspondence should be addressed. E-mail: ggurtner{at}stanford.edu.
Objective—The mechanism of neovascularization during the proliferative phase of infantile hemangioma is poorly understood. It is known that circulating bone marrow–derived endothelial progenitor cells (EPCs) form new blood vessels in ischemic tissues using mediators regulated by the transcription factor, HIF-1
. Mobilization of EPCs is enhanced by VEGF-A, matrix metalloproteinase (MMP)-9, and estrogen, whereas homing is secondary to localized expression of stromal cell–derived factor-1 (SDF-1). We examined whether these mediators of EPC trafficking are upregulated during the proliferation of infantile hemangioma.
Methods and Results—Surgical specimens and blood samples were obtained from children with proliferating hemangioma and age-matched controls (n=10, each group). VEGF-A and MMP-9 levels were measured in blood, and tissue sections were analyzed for SDF-1, MMP-9, VEGF-A, and HIF-1. The role of estrogen as a modulator of hemangioma endothelial cell growth was also investigated. We found that all these mediators of EPC trafficking are elevated in blood and specimens from children with proliferating infantile hemangioma. In vitro, the combination of hypoxia and estrogen demonstrated a synergistic effect on hemangioma endothelial cell proliferation.
Conclusions—These findings demonstrate that proliferating hemangiomas express known mediators of vasculogenesis and suggest that this process may play a role in the initiation or progression of this disease.
Key words: hemangioma • hypoxia • vasculogenesis • endothelial progenitor cells • chemokines
This article has been cited by other articles:
 |
|
 |
|
  V. Sans, E. D. de la Roque, J. Berge, N. Grenier, F. Boralevi, J. Mazereeuw-Hautier, D. Lipsker, E. Dupuis, K. Ezzedine, P. Vergnes, et al. Propranolol for Severe Infantile Hemangiomas: Follow-Up Report Pediatrics, September 1, 2009; 124(3): e423 - e431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Praveen, R. Vidavalur, T. S. Rosenkrantz, and N. Hussain Infantile Hemangiomas and Retinopathy of Prematurity: Possible Association Pediatrics, March 1, 2009; 123(3): e484 - e489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Garzon, B. A. Drolet, E. Baselga, S. L. Chamlin, A. N. Haggstrom, K. Horii, A. W. Lucky, A. J. Mancini, D. W. Metry, B. Newell, et al. Comparison of Infantile Hemangiomas in Preterm and Term Infants: A Prospective Study Arch Dermatol, September 1, 2008; 144(9): 1231 - 1232. [Full Text] [PDF]
|
|